Pyridine

Pyridine

SCHEMBL546119

CS(=O)(=O)O.c1ccncc1

nearest known ligand 0.53

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ABL1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB2AGTR1BCL2BCL2A1BCL2L1BCL2L10BCL2L2BCRBRAFCHRM1CHRNA10CHRNA9DRD1DRD2DRD3DRD4DRD5EGFRF2FLT1FLT4GCKGHSRGNRHRGRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BHTR1AHTR1BHTR1DHTR2AHTR2CHTR3AIDH2KDRKITMAOBMCL1MTTPPP4HBPDGFRBPIK3CAPIK3CBPIK3CDPIK3CGPIK3R1PIK3R2PIK3R3PIK3R5PIKFYVEROCK1ROCK2SLC18A2SLC6A2SLC6A3SLC6A4TACR1TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8gyrAgyrBparCparEpol

The experimentally established mechanism targets of Pyridine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NAPRT Q6XQN6 2/20 0.53
TDP1 Q9NUW8 2/20 0.53
TSHR P16473 2/20 0.53
LMNA P02545 2/20 0.38
ALDH1A1 P00352 2/20 0.35
HPGD P15428 2/20 0.34
PTGS2 P35354 3/20 0.33
TAAR1 Q96RJ0 1/20 0.33
PLOD2 O00469 1/20 0.33
PLOD3 O60568 1/20 0.33
CYP1A2 P05177 1/20 0.33
CYP3A4 P08684 1/20 0.33
CYP2D6 P10635 1/20 0.33
CYP2C9 P11712 1/20 0.33
CYP2C19 P33261 1/20 0.33
PLOD1 Q02809 1/20 0.33
HIF1A Q16665 1/20 0.33
CA2 P00918 1/20 0.33
GAA P10253 1/20 0.33
KEAP1 Q14145 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Pyridine SCHEMBL10678990 1.00 NAPRT (0.53) NAPRTTDP1TSHRLMNAALDH1A1
Benzene SCHEMBL27460903 1.00 NAPRT (0.53) NAPRTTDP1TSHRLMNAALDH1A1
Pyridine SCHEMBL28192777 1.00 NAPRT (0.53) NAPRTTDP1TSHRLMNAALDH1A1
Pyridine SCHEMBL28275562 0.97 NAPRT (0.50) NAPRTTDP1TSHRLMNAALDH1A1
Pyridine SCHEMBL8371169 0.97 NAPRT (0.50) NAPRTTDP1TSHRLMNAALDH1A1
Pyridine SCHEMBL28751369 0.97 NAPRT (0.50) NAPRTTDP1TSHRLMNAALDH1A1
Pyridine SCHEMBL28392625 0.95 NAPRT (0.47) NAPRTTDP1TSHRLMNAALDH1A1
Pyridine SCHEMBL29135433 0.90 TDP1 (0.43) NAPRTTDP1TSHRLMNAALDH1A1
Pyridine SCHEMBL9258140 0.90 TDP1 (0.43) NAPRTTDP1TSHRLMNAALDH1A1
Pyridine SCHEMBL20972307 0.88 NAPRT (0.53) NAPRTTDP1TSHRLMNAALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 314 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119504378-A Method for preparing p- (1-ethoxyethoxy) styrene 贵港市微芯科技有限公司 2025-02-25 CN claimed
CN-118930474-A Preparation method of key intermediate of ulcerative colitis treatment drug 北京康立生医药技术开发有限公司 2024-11-12 CN claimed
CN-118851982-A Preparation method of itramod key intermediate 北京康立生医药技术开发有限公司 2024-10-29 CN claimed
CN-118745126-A Synthesis method of p-chloromethyl styrene 北京联本医药化学技术有限公司 2024-10-08 CN claimed
CN-118546265-A Cellulose aldehyde and preparation method and application thereof 新疆农业大学 2024-08-27 CN claimed
CN-115974659-B Synthesis method of 1- (1-ethoxyethoxy) -4-vinylbenzene 徐州博康信息化学品有限公司 2024-08-09 CN claimed
CN-117702170-A Preparation method for constructing atomic-level tungsten-based energy storage/electrocatalytic material with assistance of ionic liquid 江苏大学 2024-03-15 CN claimed
CN-117285542-A Preparation method of balo Sha Weizhi and key intermediate thereof 广西天铭药业有限公司 2023-12-26 CN claimed
CN-117209499-A Preparation method of ertapenem amide and application of ertapenem amide in preparation quality research 重庆圣华曦药业股份有限公司 2023-12-12 CN claimed
CN-113880689-B Preparation method of 3-methyl-1, 5-pentanediol 万华化学集团股份有限公司 2023-05-30 CN claimed
EP-0915092-A1 Process for the preparation of 6-(arylcarbonyl)-4-oximo-dihydrobenzothiopyran herbicides and intermediates useful therein American Cyanamid Company (US) 1999-05-12 EP claimed
EP-0577302-B1 Process for preparing alpha-anomer enriched 2-deoxy-2,2-difluoro-D-ribofuranosyl sulfonates LILLY CO ELI (US) 1997-07-16 EP claimed
EP-0640614-B1 Stereoselective process for preparing beta-anomer enriched 2-deoxy-2, 2-difluoro-d-ribofuranosyl-3, 5-hydroxy protected-1-alkyl and aryl sulfonate intermediates LILLY CO ELI (US) 1996-12-04 EP claimed
US-5424416-A Sulfonating a lactol, followed with nucleobase anion, forming anomers ELI LILLY AND COMPANY (US) 1995-06-13 US claimed
EP-0640614-A2 Stereoselective process for preparing beta-anomer enriched 2-deoxy-2, 2-difluoro-d-ribofuranosyl-3, 5-hydroxy protected-1-alkyl and aryl sulfonate intermediates ELI LILLY AND COMPANY (US) 1995-03-01 EP claimed
EP-0577302-A1 Process for preparing alpha-anomer enriched 2-deoxy-2,2-difluoro-D-ribofuranosyl sulfonates ELI LILLY AND COMPANY (US) 1994-01-05 EP claimed
US-5256798-A Treating beta-anomer ribofuranosyl sulfonate with source of conjugate anion ELI LILLY AND COMPANY (US) 1993-10-26 US claimed
US-4845219-A ANTITUMOR, ANTOCOAGULANT TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1989-07-04 US claimed
EP-0255366-A2 Nitrogen- and sulfur-containing lipid compound, their production and use Takeda Chemical Industries, Ltd. (JP) 1988-02-03 EP claimed
US-4448779-A 5-O-CYANOBENZYL-4,5,6,7-TETRAHYDROTHIENO(3,2-C)PYRIDINE SANOFI (FR) 1984-05-15 US claimed